Echosens to Address GLP-1 Costs and Metabolic Health at SIIA National Conference 2026, Highlight Opportunities for Self-Insured Stakeholders and On-Site Clinics

Echosens , a global leader in non-invasive liver diagnostics and maker of FibroScan®, announces that Shawn McGinnis, Director, Health Systems and Employer Markets, Echosens, will participate in the ...
Yahoo Finance

FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan®) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials

WESTBOROUGH, Mass., Sept. 8, 2025 /PRNewswire/ -- Echosens, the leader in non-invasive liver diagnostics, is announcing today that the U.S. Food and Drug Administration's (FDA's) Center for Drug ...
Business Wire

Echosens Introduces FibroScan 630 Expert: Adds New Spleen Stiffness Measurement (SSM by VCTE™) for Risk Stratification of Patients with Advanced Chronic Liver Disease

WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, announces the launch of FibroScan 630 Expert in the United States, a comprehensive ...
Onlymyhealth on MSN

Who should get a FibroScan? Gastroenterologist explains who may need this liver test

A FibroScan is a non-invasive test that can help doctors assess the health of the liver without a biopsy. It measures liver stiffness, which can indicate the presence and severity of liver fibrosis, ...
Business Wire

Boost Workforce Productivity, Reduce Medical Costs: Integrate Echosens’ FibroScan Into MetaPhy’s Chronic Care Liver Disease Management Program

WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, today announces the release of its white paper “Comprehensive Chronic Care Disease ...
FierceBiotech

Novo Nordisk, Echosens aim to double NASH diagnostic rate by expanding test options, awareness

Echosens’ FibroScan is a standalone device that healthcare providers can use to perform noninvasive liver scans, offering a faster and simpler alternative to invasive biopsies for liver disease ...
Morningstar%2c Inc.

Echosens Shares BlueCross BlueShield of Tennessee Medical Policy Update Clarifying Coverage for FibroScan® and Other Noninvasive Elastography Technologies

WESTBOROUGH, Mass., July 15, 2026 /PRNewswire/ -- Echosens today announced that BlueCross BlueShield of Tennessee (BCBSTN) has revised its medical policy governing noninvasive imaging for chronic ...
timesofoman

State-of-the-art FibroScan service launched in Oman

Muscat: Oman International Hospital has launched the state-of-the-art FibroScan service, a modern non-invasive technology for detecting scarring (fibrosis) and fat deposition (steatosis) in patients ...